- |||||||||| vernakalant oral / Merck (MSD), Brinavess (vernakalant) / Merck (MSD), Correvio
Retrospective data, Review, Journal: Pharmacologic Cardioversion in Patients with Paroxysmal Atrial Fibrillation: A Network Meta-Analysis. (Pubmed Central) - Dec 16, 2021
Our network meta-analysis identified with sufficient power and consistency the most effective antiarrhythmics for pharmacologic cardioversion over different time settings, with vernakalant and flecainide exhibiting a safer and more efficacious profile toward faster cardioversion.
|
